Arrowhead, Sarepta Skyrocket After Duo Inks A Whopping $11.38 …

The deal is worth a whopping $11.38 billion over the next five years. It includes $825 million upfront, consisting of a payment and an equity investment at a 35% premium.

35%
OFF

Arrowhead, Sarepta Skyrocket After Duo Inks A Whopping $11.38 …

2 weeks from now

The deal is worth a whopping $11.38 billion over the next five years. It includes $825 million upfront, consisting of a payment and an equity investment at a 35% premium.

msn.com

$11.38
OFF

Arrowhead, Sarepta Skyrocket After Duo Inks A Whopping $11.38 …

2 weeks from now

Nov 26, 2024 · Arrowhead, Sarepta Skyrocket After Duo Inks A Whopping $11.38 Billion Deal Shares of Arrowhead Pharmaceuticals catapulted Tuesday after the company inked a broad …

yahoo.com

2%
OFF

Arrowhead, Sarepta Skyrocket After Duo Inks A Whopping $11.38 …

2 weeks from now

Nov 26, 2024 · Over the last five years, the Dow has produced a respectable 68.2% total return, but that's quite a bit lower than the S&P 500's 102.8% or the Nasdaq's 132.7% total return …

yahoo.com

35%
OFF

Arrowhead, Sarepta Skyrocket After Duo Inks A Whopping…

2 weeks from now

Nov 26, 2024 · The deal is worth a whopping $11.38 billion over the next five years. It includes $825 million upfront, consisting of a payment and an equity investment at a 35% premium. …

inkl.com

$11
OFF

Arrowhead Pharma Inks Licensing Deal With Sarepta, Stock Jumps

2 weeks from now

Nov 26, 2024 · Arrowhead Pharma Inks Licensing Deal With Sarepta, Stock Jumps ... The deal is valued at up to $11.3 billion, including $825 million in immediate payments and the potential …

nasdaq.com

$11.38
OFF

Arrowhead Pharmaceuticals Stock Soars After $11.38 Billion Deal …

2 weeks from now

Los Angeles, California – Arrowhead Pharmaceuticals (ARWR) saw a surge in its stock prices on Tuesday following a significant licensing agreement with Sarepta Therapeutics (SRPT) for a …

absolutenews.com

16%
OFF

Arrowhead Stock Rockets 16% After Major Licensing Deal

2 weeks from now

Nov 27, 2024 · Arrowhead Pharmaceuticals (ARWR, Financial) had investors buzzing this morning, with shares rocketing nearly 16% after announcing a blockbuster licensing and …

gurufocus.com

$11.38
OFF

Arrowhead And Sarepta Seal $11.38 Billion Global Licensing Deal …

2 weeks from now

Nov 27, 2024 · US-based companies Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) and Sarepta Therapeutics (NASDAQ: SRPT) have announced a significant global licensing …

flcube.com

15%
OFF

Sarepta Therapeutics, Arrowhead Pharmaceuticals Ink …

2 weeks from now

Nov 26, 2024 · Arrowhead will also receive $250 million in future payments, paid in installments over the next five years. Arrowhead shares rose 15% to $21.63 after the agreement was announced, while Sarepta ...

marketwatch.com

$1
OFF

Sarepta Deal With Arrowhead Creates Major Catalysts, Says BMO …

2 weeks from now

Nov 26, 2024 · Sarepta’s partnership with Arrowhead , under which Sarepta will provide $1.4B in upfront, equity, and milestone payments in exchange for exclusive worldwide license of four …

businessinsider.com

$11
OFF

SRPT Inks $11B Licensing Deal With Arrowhead For Rare Gene …

2 weeks from now

Nov 27, 2024 · Financial Terms of the Sarepta-Arrowhead Deal In exchange for acquiring these rights, Sarepta will make an upfront payment of $500 million plus an equity investment of $325 million in Arrowhead ...

yahoo.com

$11
OFF

SRPT Inks $11B Licensing Deal With Arrowhead For Rare Gene

2 weeks from now

Nov 27, 2024 · Financial Terms of the Sarepta-Arrowhead Deal In exchange for acquiring these rights, Sarepta will make an upfront payment of $500 million plus an equity investment of $325 …

nasdaq.com

35%
OFF

Sarepta, Arrowhead Ink $1B-plus Deal For Seven Programs

2 weeks from now

Nov 26, 2024 · Sarepta’s equity investment in Arrowhead’s common stock represents a 35% premium to the biotech’s 30-day volume weighted average price, according to a Nov. 26 …

fiercebiotech.com

14%
OFF

SRPT Inks $11B Licensing Deal With Arrowhead For Rare Gene …

2 weeks from now

Shares of Sarepta Therapeutics SRPT rose nearly 14% on Tuesday after announcing that it has entered into an exclusive global licensing and collaboration agreement with Arrowhead …

msn.com

FAQs about Arrowhead, Sarepta Skyrocket After Duo Inks A Whopping $11.38 … Coupon?

How much does Sarepta pay Arrowhead?

Under the terms of the deal, Sarepta will pay Arrowhead $500 million upfront and make a $325 million equity investment to gain access to Arrowhead's gene silencing technologies, which are focused on developing treatments for rare genetic diseases affecting muscles, the central nervous system, and lungs. ...

How much is Sarepta worth?

The deal is worth a whopping $11.38 billion over the next five years. It includes $825 million upfront, consisting of a payment on an equity investment at a 35% premium. Sarepta will also pay $250 million over the next five years, an additional $300 million in near-term milestones, and up to $10 billion in future milestones and royalties on sales. ...

What's going on with Arrowhead Pharmaceuticals (Arwr)?

Shares of Arrowhead Pharmaceuticals (ARWR) catapulted Tuesday after the company inked a broad licensing deal with Sarepta Therapeutics (SRPT) for an array of gene-silencing products. Biotech Stocks Are Shooting Higher. Here's How You Can Play Them. The deal is worth a whopping $11.38 billion over the next five years. ...

Does Sarepta own Arrowhead?

Per the deal terms, Sarepta will acquire exclusive rights to Arrowhead’s seven pipeline programs, which include four in active clinical development and the remaining three in preclinical development. These programs are being developed against a broad range of genetic diseases in muscle, central nervous system (CNS) and rare pulmonary disorders. ...

Is Arrowhead stock a boon for Sarepta?

Arrowhead shares rocketed 12% to close at 21.05 and ARWR stock leapfrogged its 50-day line, according to MarketSurge. Sarepta stock jumped too, 13.8% to 130.50, putting it above its 50-day moving average for the first time since Nov. 7. The deal is also a boon for Sarepta, RBC Capital Markets analyst Brian Abrahams said in a client note. ...

How did Arrowhead & Sarepta stock perform in morning trades?

In morning trades, Arrowhead shares rocketed more than 17% to 22.06 and ARWR stock leapfrogged its 50-day line, according to MarketSurge. Sarepta stock jumped too, up 7.2% to 122.93, putting it above its 50-day moving average for the first time since Nov. 7. ...